Invo Bioscience Inc (IVOB) Major Shareholder Claude Ranoux Sells 100,000 Shares

Invo Bioscience Inc (OTCMKTS:IVOB) major shareholder Claude Ranoux sold 100,000 shares of the firm’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $0.13, for a total transaction of $13,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Claude Ranoux also recently made the following trade(s):

  • On Thursday, January 4th, Claude Ranoux sold 2,834 shares of Invo Bioscience stock. The stock was sold at an average price of $0.15, for a total transaction of $425.10.
  • On Friday, December 29th, Claude Ranoux sold 4,525 shares of Invo Bioscience stock. The stock was sold at an average price of $0.16, for a total transaction of $724.00.
  • On Wednesday, December 27th, Claude Ranoux sold 10,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.17, for a total transaction of $1,700.00.
  • On Wednesday, December 20th, Claude Ranoux sold 10,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.17, for a total transaction of $1,700.00.
  • On Monday, December 18th, Claude Ranoux sold 30,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.17, for a total transaction of $5,100.00.
  • On Monday, December 11th, Claude Ranoux sold 50,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.18, for a total transaction of $9,000.00.

Invo Bioscience Inc (OTCMKTS:IVOB) opened at $0.15 on Wednesday. The company has a debt-to-equity ratio of -0.03, a current ratio of 0.03 and a quick ratio of 0.02. Invo Bioscience Inc has a 52-week low of $0.08 and a 52-week high of $0.40. The stock has a market cap of $21.25, a PE ratio of -15.00 and a beta of 1.72.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2018/01/10/invo-bioscience-inc-ivob-major-shareholder-claude-ranoux-sells-100000-shares.html.

Invo Bioscience Company Profile

INVO Bioscience, Inc is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company’s product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC).

Receive News & Ratings for Invo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit